# Dose Escalation Study of Pazopanib Plus TH-302

> **NCT01485042** · PHASE1 · COMPLETED · sponsor: **Herbert Hurwitz, MD** · enrollment: 50 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Pazopanib and TH-302

## Key facts

- **NCT ID:** NCT01485042
- **Lead sponsor:** Herbert Hurwitz, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-02
- **Final completion:** 2014-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-09-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485042, "Dose Escalation Study of Pazopanib Plus TH-302". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01485042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*